These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 25173640)

  • 1. Expression of BTG1 in hepatocellular carcinoma and its correlation with cell cycles, cell apoptosis, and cell metastasis.
    Sun GG; Lu YF; Cheng YJ; Yang CR; Liu Q; Jing SW; Han XC
    Tumour Biol; 2014 Dec; 35(12):11771-9. PubMed ID: 25173640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BTG1 expression correlates with the pathogenesis and progression of breast carcinomas.
    Sheng SH; Zhao CM; Sun GG
    Tumour Biol; 2014 Apr; 35(4):3317-26. PubMed ID: 24272202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of BTG1 is downregulated in NSCLC and possibly associated with tumor metastasis.
    Sun GG; Lu YF; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):2949-57. PubMed ID: 24264312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The expression of BTG1 is downregulated in nasopharyngeal carcinoma and possibly associated with tumour metastasis.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Mol Biol Rep; 2014 Sep; 41(9):5979-88. PubMed ID: 24985971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BTG1 underexpression is an independent prognostic marker in esophageal squamous cell carcinoma.
    Sun GG; Wang YD; Cheng YJ; Hu WN
    Tumour Biol; 2014 Oct; 35(10):9707-16. PubMed ID: 24969561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abnormal expression and mechanism of miR-330-3p/BTG1 axis in hepatocellular carcinoma.
    Zhao X; Chen GQ; Cao GM
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6888-6898. PubMed ID: 31486488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BTG1 expression in thyroid carcinoma: diagnostic indicator and prognostic marker.
    Lu YF; Sun GG; Liu Q; Yang CR; Cheng YJ
    Int J Oncol; 2014 Oct; 45(4):1574-82. PubMed ID: 25017022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Expression of SETD7 Promotes Cell Proliferation by Regulating Cell Cycle and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Chen Y; Yang S; Hu J; Yu C; He M; Cai Z
    PLoS One; 2016; 11(5):e0154939. PubMed ID: 27183310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpressed GNAZ predicts poor outcome and promotes G0/G1 cell cycle progression in hepatocellular carcinoma.
    Tian F; Cai D
    Gene; 2022 Jan; 807():145964. PubMed ID: 34530087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antiproliferative gene FLNA regulates migration and invasion of gastric carcinoma cell in vitro and its clinical significance.
    Sun GG; Sheng SH; Jing SW; Hu WN
    Tumour Biol; 2014 Mar; 35(3):2641-8. PubMed ID: 24241900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. B cell translocation gene 1 reduces the biological outcome of kidney cancer through induction of cell proliferation, cell cycle arrest, cell apoptosis and cell metastasis.
    Sun G; Liu Q; Cheng Y; Hu W
    Int J Mol Med; 2015 Mar; 35(3):777-83. PubMed ID: 25571854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BTG1 expression correlates with pathogenesis, aggressive behaviors and prognosis of gastric cancer: a potential target for gene therapy.
    Zheng HC; Li J; Shen DF; Yang XF; Zhao S; Wu YZ; Takano Y; Sun HZ; Su RJ; Luo JS; Gou WF
    Oncotarget; 2015 Aug; 6(23):19685-705. PubMed ID: 26050197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EMP1 inhibits nasopharyngeal cancer cell growth and metastasis through induction apoptosis and angiogenesis.
    Sun GG; Lu YF; Fu ZZ; Cheng YJ; Hu WN
    Tumour Biol; 2014 Apr; 35(4):3185-93. PubMed ID: 24292952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of low expression of B-cell translocation gene 1 (
    Li G; Yue Y; Li W; Chen Y; Fan H; Yuan J; Chen Z; Liu J
    J Biosci; 2020; 45():. PubMed ID: 32457282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD109 Mediates Cell Survival in Hepatocellular Carcinoma Cells.
    Zong G; Xu Z; Zhang S; Shen Y; Qiu H; Zhu G; He S; Tao T; Chen X
    Dig Dis Sci; 2016 Aug; 61(8):2303-2314. PubMed ID: 27074923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High expression of G-protein signaling modulator 2 in hepatocellular carcinoma facilitates tumor growth and metastasis by activating the PI3K/AKT signaling pathway.
    He XQ; Zhang YF; Yu JJ; Gan YY; Han NN; Zhang MX; Ge W; Deng JJ; Zheng YF; Xu XM
    Tumour Biol; 2017 Mar; 39(3):1010428317695971. PubMed ID: 28347229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of LZAP as a new candidate tumor suppressor in hepatocellular carcinoma.
    Zhao JJ; Pan K; Li JJ; Chen YB; Chen JG; Lv L; Wang DD; Pan QZ; Chen MS; Xia JC
    PLoS One; 2011; 6(10):e26608. PubMed ID: 22028922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibulin-5 inhibits hepatocellular carcinoma cell migration and invasion by down-regulating matrix metalloproteinase-7 expression.
    Tu K; Dou C; Zheng X; Li C; Yang W; Yao Y; Liu Q
    BMC Cancer; 2014 Dec; 14():938. PubMed ID: 25494879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. B‑cell translocation gene 1 serves as a novel prognostic indicator of hepatocellular carcinoma.
    Kanda M; Sugimoto H; Nomoto S; Oya H; Hibino S; Shimizu D; Takami H; Hashimoto R; Okamura Y; Yamada S; Fujii T; Nakayama G; Koike M; Fujiwara M; Kodera Y
    Int J Oncol; 2015 Feb; 46(2):641-8. PubMed ID: 25405901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.